Boosting mRNA Potential for Therapeutics, Gene-Editing & Vaccine Applications With Scalable Design, Guided Delivery, & Validated Clinical Safety for Patients
With proof-of-concept after the COVID-19 pandemic, the mRNA space stands on firmer ground and is now making headlines that prove its value across new diseases. From MHRA’s latest guidance on mRNA personalized cancer vaccines to the world’s first RNA-based CRISPR therapy for Baby KJ, doors are opening to revolutionary therapeutics and gene editing applications.
The 5th mRNA-Based Therapeutics Summit Europe is the ultimate biopharma platform diving into novel mRNA, sa-RNA and circular RNA design to delivery innovations, giving you the latest insights and connections to turn these breakthroughs into action. Enhanced with the brand-new Gene Editing Focus Day to harness mRNA's power through transient editing strategies, and Investor-Led sessions on what makes an mRNA platform fundable in 2026, leave this meeting with tried and tested strategies to de-risk your programs and secure partnerships in today’s competitive landscape.
Join 170+ senior leaders from Moderna, AstraZeneca, CybernaX Bio, Avocet Bio, and others working on R&D, CMC, business development, and regulatory affairs for three days of learning, networking, and collaboration to put you at the forefront of mRNA and gene editing innovation in 2026.
Data from later clinical development stage/clinical data was presented. This was interesting.
Senior Vice President, BioNTech
This was an excellent conference, by far one of the best mRNA conferences I have attended. Excellent meeting to meet the leaders in the field. The scientific program, the exchange and the networking were excellent.
Chief Executive Officer, DivinCell
The diversity of topics and attendees was good (suppliers, drug developers, CDMOs, regulatory specialists)
Director, Merck KGaA
Explore the Full Event Guide
- Reshape gene editing strategies with mRNA and explore its role in safer, transient editing, novel delivery approaches, with translational case studies giving you actionable insights to advance next-generation therapies
- Uncover the latest clinical and preclinical insights and find solutions to advance technology innovation and manufacturing, including mRNA architecture and LNP design
- Connect with leading biopharma and position your team at the forefront of emerging therapeutic opportunities, with firsthand insights into investment trends, partnerships, and expansion into mRNA drug pipelines
Official Partners
Attending Companies Include
Explore the Agenda
Dive into cutting-edge mRNA-based therapeutics with insights from leading biopharma, biotech, and academic experts.
Partner With Us
Showcase your technologies and services to senior decision-makers driving next-generation mRNA innovation.
Join Biopharma Experts
Be part of the only European meeting uniting pre-clinical, clinical, manufacturing, regulatory, and investor experts in the mRNA space.